
Precipio launches promising assay for hematologic cancers
Specialty cancer diagnostics company Precipio Inc. launches HemeScreen, a novel proprietary test for mutations in hematologic cancers that shows significant promise. They are the first […]
Specialty cancer diagnostics company Precipio Inc. launches HemeScreen, a novel proprietary test for mutations in hematologic cancers that shows significant promise. They are the first […]
Roche announces the global availability of FoundationOne Liquid, a liquid biopsy test. Many cancer patients have an insufficient or inadequate tissue for genomic testing and may […]
MRM Proteomics Inc. partners with Exactis Innovation to develop and validate a clinical proteomic test that will provide clinicians and scientists with the ability to […]
The QuantideX NGS DNA Hotspot 21 Kit is an in vitro diagnostic, next-generation sequencing (NGS) panel for the detection of clinically relevant variants across a multitude of […]
IMV Inc., a clinical stage immuno-oncology corporation, celebrates the grand opening of its new facilities in Dartmouth, Nova Scotia. Frederic Ors, IMV’s Chief Executive Officer, […]
Orleans-based Tetra Bio-Pharma submits multiple applications of Orphan Drug Designation for cannabinoids to the U.S. Food and Drug Administration (FDA) for various forms of rare […]
HTG Molecular Diagnostics, Inc., a provider of instruments, reagents, and services for molecular profiling applications, release its HTG EdgeSeq Precision Immuno-Oncology Panel.
Advanced Proteome Therapeutics Corporation (APC) joins forces with Noria Pharmaceuticals Inc. in the rapidly growing field of antibody radioisotope conjugates.
One in 285 children in the US will be diagnosed with cancer before they see their twentieth birthday, and little until recently was known about […]
Researchers now have compelling evidence to suggest that external factors, such as air pollution, are more detrimental to lung health than genetics alone when it […]
Copyright © 2019 | WordPress Theme by MH Themes